|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn961451708 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
161029s2016 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OCLCQ
|d UKAHL
|d OCLCQ
|d REDDC
|d OCLCF
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 961205196
|
| 020 |
|
|
|a 9783319388724
|
| 020 |
|
|
|a 331938872X
|
| 020 |
|
|
|z 9783319388717
|
| 020 |
|
|
|z 3319388711
|
| 035 |
|
|
|a (OCoLC)961451708
|z (OCoLC)961205196
|
| 050 |
|
4 |
|a R1
|
| 082 |
0 |
4 |
|a 610
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Penteado Schmidt, Carolina Witchmichen.
|
| 245 |
1 |
0 |
|a Drug Therapy and Interactions in Pediatric Oncology :
|b a Pocket Guide.
|
| 260 |
|
|
|a Cham :
|b Springer International Publishing,
|c 2016.
|
| 300 |
|
|
|a 1 online resource (223 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Preface; Abstract; Acknowledgments, fromÈCarolina Witchmichen Penteado Schmidt; Contents; Authors; Abbreviations and Acronyms; Chapter 1: Introduction; 1.1 Childhood Cancer inËurope; 1.2 Childhood Cancer inÈNorth America; 1.3 Childhood Cancer inÈLatin America; 1.4 Childhood Cancer inÄfrica; 1.5 Childhood Cancer inÄsia; 1.6 Childhood Cancer inÈCentral America; 1.7 Childhood Cancer inÖceania; 1.8 Pharmacological Treatment inÈChildhood Cancer; Chapter 2: The Main Diseases inÈPediatric Hemato-oncology; 2.1 Hodgkin Lymphoma (HL); 2.2 Non-Hodgkin Lymphoma (NHL).
|
| 505 |
8 |
|
|a 2.3 Chronic Myeloid Leukemia (CML)2.4 Acute Myeloid Leukemia (AML); 2.5 Acute Lymphoblastic Leukemia (ALL); 2.6 Osteosarcoma; 2.7 Central Nervous System (CNS) Tumors; Chapter 3: The Main Protocols inÈPediatric Oncohematology; 3.1 Hodgkin Lymphoma; 3.2 Chronic Myeloid Leukemia (CML); 3.2.1 Hematological Control withḦydroxyurea; 3.2.2 Imatinib; 3.3 Acute Myeloid Leukemia (AML); 3.3.1 Protocol ofẗheÈGerman Group forÄcute Myeloid Leukemia Treatment Berlin-©Frankfurt-©MŁunster (BFM2004): Adapted fromḦEMORIO; 3.3.2 IDA-FLAG Protocol (Idarubicin, Fludarabine, Cytarabine, andÈFilgrastim).
|
| 505 |
8 |
|
|a 3.4 Acute Lymphoid Leukemia (ALL)3.4.1 Protocol ofÈLeukemia Treatment ofẗheÈGerman Group BerlinÈ- FrankfurtÈ- MŁunsten, ofÈ1995, forÄcute Lymphoid Leukemia (BFM95) ; 3.4.2 Therapy forÈLow-Risk Patients withẗheÈProtocol ofẗheÈBrazilian Childhood Cooperative Group ofÈ1999 (GBTLI ALL-99); 3.4.3 Protocol ofẗheÈBerlin-Frankfurt-MŁunster Group, ALL IC-BFM 2002, forÄcute Lymphoid Leukemia; 3.5 Brain Tumors; 3.5.1 High-Dose Protocol: Cyclophosphamide, Doxorubicin, andÈVincristine (HD-CAV) (Neuroblastoma) [63]; 3.5.2 Cyclophosphamide, Vincristine, Cisplatin, andËtoposide (COPE/Baby Brain I) [4].
|
| 505 |
8 |
|
|a 3.5.3 Eight inÖne (8 inÈ1) [4]3.5.4 Cyclophosphamide, Doxorubicin, Vincristine, Cisplatin, andËtoposide (CAV-P/VP) (Neuroblastoma) [4]; 3.6 Wilms Tumor; 3.6.1 Doxorubicin, Vincristine, andÈDactinomycin (AVD) [4]; 3.6.2 Dactinomycin andÈVincristine (AV) (Stage IV andÈFavorable Histology) [4]; 3.7 Retinoblastoma; 3.7.1 Cyclophosphamide, Cisplatin, Doxorubicin, and Etoposide (CCDE) [4]; 3.8 Non-Hodgkin Lymphoma; 3.9 High-Risk Central Nervous System B Non-Hodgkin Lymphoma andÈB Acute Lymphoblastic Leukemia: Protocol ofẗheÈFrench Society ofÈPediatric Oncology LMB86.
|
| 505 |
8 |
|
|a 3.10 Advanced Burkitt's Lymphoma andÄLL L3È- Protocol forÈBurkitt's Lymphoma ofẗheÈFrench Society ofÈPediatric Oncology (LMB89)3.11 Osteosarcoma; 3.11.1 High-Dose Methotrexate (HD MTX) [4]; 3.11.2 Ifosfamide, Carboplatin, andËtoposide (ICE) (for Malignant Recurrent Solid Tumors) [4]; 3.12 Hepatoblastoma; Chapter 4: Background ofÈDrug Interactions; 4.1 Basis ofÈDrug Interactions; 4.1.1 Pharmacokinetic Interactions; 4.1.2 Pharmacodynamic Interactions; 4.2 Drug: Drug Interactions; 4.2.1 Drug Interactions (Pharmacokinetics) Involving CYP450.
|
| 500 |
|
|
|a 4.2.2 Drug Interactions (Pharmacokinetics) Involving Binding Proteins andÄffinity forÈPlasma Proteins.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Tumors in children
|x Chemotherapy.
|
| 650 |
|
0 |
|a Pediatric pharmacology.
|
| 650 |
|
6 |
|a Pharmacologie pĐediatrique.
|
| 650 |
|
7 |
|a Pediatric pharmacology
|2 fast
|
| 650 |
|
7 |
|a Tumors in children
|x Chemotherapy
|2 fast
|
| 700 |
1 |
|
|a De Menezes, Fabiana Gatti.
|
| 758 |
|
|
|i has work:
|a Drug therapy and interactions in pediatric oncology (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYYwXqMcBjmqKF98xkY7H3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Penteado Schmidt, Carolina Witchmichen.
|t Drug Therapy and Interactions in Pediatric Oncology : A Pocket Guide.
|d Cham : Springer International Publishing, Ã2016
|z 9783319388717
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4722677
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH32381358
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4722677
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13231067
|
| 994 |
|
|
|a 92
|b IZTAP
|
